MTVA MetaVia Inc.
$1.15▼ -5.35%
Healthcare
Other
Volume 67.7K
Avg Volume (10D) 61.8K
Key Metrics & Fundamentals
Market Cap
$7.58M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.97 - 14.85
% vs 50 MA
-25.49%
% vs 200 MA
-34.89%
RSI-14
31.2
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.56
Free Cash Flow
-$3.76M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$5.38M
COGS
–
Operating Exp
$5.39M
Operating Income
-$5.39M
EBIT
-$5.39M
Pretax Income
-$5.32M
Net Income
-$5.32M
EPS (Diluted)
-0.90
Price & Volume History
Loading chart…
Recent News
MetaVia Appoints Seasoned Clinical Development Executive Sarah Browne, M.D., as Chief Medical Officer
PR Newswire · Oct 13, 2026 8:31 AM ET
MTVA: Preclinical Findings Support DA-1726 Waist Circumference Reduction
Zacks Small Cap Research · Sep 10, 2026 8:25 AM ET
MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction
PR Newswire · Sep 9, 2026 8:00 AM ET
MTVA: Dose Titration Complete in Phase 1 Part 3 Study of DA-1726
Zacks Small Cap Research · Aug 12, 2026 8:20 AM ET
MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update
PR Newswire · Aug 6, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MTVA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.